
Tofajak contains Tofacitinib 5 mg, a Janus kinase (JAK) inhibitor used primarily to treat autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
| Generic Name | Tofacitinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Treat specific moderate-to-severe autoimmune and inflammatory conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Tofacitinib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Dr. Anjali Desai holds a Doctor of Medicine (MD) degree and has a professional interest in rheumatoid arthritis and joint care. Her interests include managing symptoms, monitoring disease progression, supporting treatment plans and improving patients’ quality of life.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.